SCHEMBL4565948

SCHEMBL4565948

Ic1ccccn1.O=C(O)CN(c1ccc2c(ccn2-c2ccccn2)c1)S(=O)(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 10/20 0.36
NFE2L2 Q16236 10/20 0.36
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
S1PR1 P21453 1/20 0.34
PLAU P00749 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
F2 P00734 1/20 0.34
ADRB2 P07550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10357252 0.95 ALDH1A1 (0.39) KEAP1NFE2L2ALDH1A1L3MBTL1S1PR1
SCHEMBL4428677 0.86 KEAP1 (0.34) KEAP1NFE2L2ALDH1A1L3MBTL1S1PR1
SCHEMBL3298487 0.85 ALDH1A1 (0.39) KEAP1NFE2L2ALDH1A1L3MBTL1S1PR1
SCHEMBL4441320 0.84 KEAP1 (0.34) KEAP1NFE2L2ALDH1A1L3MBTL1PLAU
SCHEMBL4432779 0.84 KEAP1 (0.35) KEAP1NFE2L2ALDH1A1L3MBTL1S1PR1
SCHEMBL3300825 0.84 KEAP1 (0.38) KEAP1NFE2L2ALDH1A1L3MBTL1PLAU
SCHEMBL13390554 0.83 KMT2A (0.36) ALDH1A1S1PR1MEN1KMT2AADRB2
SCHEMBL3304036 0.83 KEAP1 (0.41) KEAP1NFE2L2
SCHEMBL13391160 0.83 ROCK1 (0.35) KEAP1NFE2L2ALDH1A1L3MBTL1PLAU
SCHEMBL3299475 0.83 KDM4C (0.37) KEAP1NFE2L2ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed